Beijing, China

Changwei Mu


 

 

Average Co-Inventor Count = 11.7

ph-index = 2

Forward Citations = 13(Granted Patents)


Company Filing History:


Years Active: 2014-2018

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: Changwei Mu: Innovator in Pharmaceutical Research

Introduction

Changwei Mu is a prominent inventor based in Beijing, China. He has made significant contributions to the field of pharmaceutical research, particularly in the development of compounds that target specific diseases. With a total of eight patents to his name, Mu's work has the potential to impact various medical conditions.

Latest Patents

Among his latest patents, Changwei Mu has developed purine inhibitors of human phosphatidylinositol 3-kinase delta. These compounds, represented by formula (I), serve as PI3K-delta inhibitors. They are particularly useful for treating PI3K-delta-mediated diseases such as inflammation, asthma, chronic obstructive pulmonary disease (COPD), and cancer. This innovative approach highlights his commitment to advancing medical treatments.

Career Highlights

Throughout his career, Changwei Mu has worked with notable companies in the pharmaceutical industry. He has been associated with Merck Sharp & Dohme Corporation and Alectos Therapeutics Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Changwei Mu has collaborated with esteemed colleagues, including Harold G. Selnick and Yaode Wang. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Changwei Mu's contributions to pharmaceutical research and his innovative patents position him as a key figure in the field. His work continues to pave the way for advancements in the treatment of various diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…